GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (HKSE:01548) » Definitions » Other Stockholders Equity

Genscript Biotech (HKSE:01548) Other Stockholders Equity : HK$258 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Genscript Biotech Other Stockholders Equity?

Genscript Biotech's Other Stockholders Equity for the quarter that ended in Jun. 2024 was HK$258 Mil.

Genscript Biotech's quarterly Other Stockholders Equity increased from Jun. 2023 (HK$375 Mil) to Dec. 2023 (HK$552 Mil) but then declined from Dec. 2023 (HK$552 Mil) to Jun. 2024 (HK$258 Mil).

Genscript Biotech's annual Other Stockholders Equity declined from Dec. 2021 (HK$582 Mil) to Dec. 2022 (HK$493 Mil) but then increased from Dec. 2022 (HK$493 Mil) to Dec. 2023 (HK$552 Mil).

Genscript Biotech Other Stockholders Equity Historical Data

The historical data trend for Genscript Biotech's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech Other Stockholders Equity Chart

Genscript Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,033.60 8,503.23 581.53 493.31 551.84

Genscript Biotech Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,024.17 493.31 375.26 551.84 258.31

Genscript Biotech Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Genscript Biotech Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Genscript Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (HKSE:01548) » Definitions » Other Stockholders Equity
Comparable Companies
HKSE:01877 HKSE:01177 HKSE:09926 HKSE:09995 HKSE:01801 HKSE:06990 HKSE:01530 HKSE:02162 HKSE:06826 HKSE:09969 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
GNNSF:USA G51:Germany
Address
No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100
Website
https://www.genscript.com
Genscript Biotech Corp is a China-based provider of life science research services and products. it is known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, The company estimates that over two-thirds of GenScript valuation is from its ownership stake in Legend.
Executives
Wang Luquan 2401 A concert party to an agreement to buy shares
Wang Ye 2101 Beneficial owner
Zhang Fangliang 2401 A concert party to an agreement to buy shares
Huang Lili 2202 Interest of your spouse
Hu Zhiyong 2201 Interest of corporation controlled by you
Jin Weihong 2201 Interest of corporation controlled by you
Genscript Corporation 2101 Beneficial owner
Hillhouse Fund V, L.p. 2201 Interest of corporation controlled by you
Hillhouse Investment Management V, Ltd. 2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd. 2102 Investment manager
Gns Holdings Limited 2101 Beneficial owner
Hillhouse Capital Management V, Ltd. 2201 Interest of corporation controlled by you
Hillhouse Capital Management, Ltd. 2102 Investment manager

Genscript Biotech Headlines

No Headlines